130 related articles for article (PubMed ID: 15782075)
1. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT), topoisomerase IIalpha expression, and apoptosis in endometrial adenocarcinoma and atypical hyperplasia.
Brustmann H
Int J Gynecol Pathol; 2005 Apr; 24(2):184-92. PubMed ID: 15782075
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
Brustmann H
Gynecol Oncol; 2005 Sep; 98(3):396-402. PubMed ID: 16005054
[TBL] [Abstract][Full Text] [Related]
3. Fas-mediated pathway and apoptosis in normal, hyperplastic, and neoplastic endometrium.
Atasoy P; Bozdoğan O; Erekul S; Bozdoğan N; Bayram M
Gynecol Oncol; 2003 Nov; 91(2):309-17. PubMed ID: 14599860
[TBL] [Abstract][Full Text] [Related]
4. Human telomerase RNA as endogenous control in endometrial tissue.
Paul-Samojedny M; Witek A; Samojedny A; Witkowska A; Wilczok T
Int J Gynecol Cancer; 2005; 15(2):343-8. PubMed ID: 15823123
[TBL] [Abstract][Full Text] [Related]
5. Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study.
Brustmann H
Gynecol Oncol; 2004 Jan; 92(1):268-76. PubMed ID: 14751170
[TBL] [Abstract][Full Text] [Related]
6. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
[TBL] [Abstract][Full Text] [Related]
7. Expression of telomerase reverse transcriptase mRNA and its quantitative analysis in human endometrial cancer.
Oshita T; Nagai N; Ohama K
Int J Oncol; 2000 Dec; 17(6):1225-30. PubMed ID: 11078809
[TBL] [Abstract][Full Text] [Related]
8. [Expression of human telomerase reverse transcriptase and c-myc transcripts in endometrial carcinoma and its precursors].
Dong Y; Li T; Wang Y; Wu HR; Xie M; Zou WZ
Zhonghua Bing Li Xue Za Zhi; 2004 Feb; 33(1):40-3. PubMed ID: 14989927
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
10. Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications.
Orlandi A; Ferlosio A; Ciucci A; Francesconi A; Lifschitz-Mercer B; Gabbiani G; Spagnoli LG; Czernobilsky B
Mod Pathol; 2006 Jun; 19(6):797-803. PubMed ID: 16575402
[TBL] [Abstract][Full Text] [Related]
11. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
[TBL] [Abstract][Full Text] [Related]
12. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF; Pizer ES; Ronnett BM; Kurman RJ
Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
[TBL] [Abstract][Full Text] [Related]
13. Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.
Watanabe J; Nishizaki R; Jobo T; Kamata Y; Hata H; Nishimura Y; Fujisawa T; Okayasu I; Kuramoto H
Int J Gynecol Pathol; 2004 Jul; 23(3):234-40. PubMed ID: 15213599
[TBL] [Abstract][Full Text] [Related]
14. Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions.
Saha B; Chaiwun B; Tsao-Wei DD; Groshen SL; Naritoku WY; Atkinson RD; Taylor CR; Imam SA
Int J Gynecol Pathol; 2007 Jul; 26(3):214-22. PubMed ID: 17581401
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.
Koshiyama M; Fujii H; Kinezaki M; Morita Y; Nanno H; Yoshida M
Anticancer Res; 2001; 21(4B):2925-32. PubMed ID: 11712788
[TBL] [Abstract][Full Text] [Related]
17. The analyses of 17beta-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma.
Utsunomiya H; Suzuki T; Kaneko C; Takeyama J; Nakamura J; Kimura K; Yoshihama M; Harada N; Ito K; Konno R; Sato S; Okamura K; Sasano H
J Clin Endocrinol Metab; 2001 Jul; 86(7):3436-43. PubMed ID: 11443221
[TBL] [Abstract][Full Text] [Related]
18. [Human telomerase P53 estrogen and progesterone receptor expression in endometrial carcinoma].
Dong Y; Li T; Liang Y; Zou WZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 36(1):61-5. PubMed ID: 14970891
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium.
Lehner R; Enomoto T; McGregor JA; Shroyer AL; Haugen BR; Pugazhenthi U; Shroyer KR
Gynecol Oncol; 2002 Jan; 84(1):120-5. PubMed ID: 11748987
[TBL] [Abstract][Full Text] [Related]
20. ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas.
Werner HM; Berg A; Wik E; Birkeland E; Krakstad C; Kusonmano K; Petersen K; Kalland KH; Oyan AM; Akslen LA; Trovik J; Salvesen HB
Mod Pathol; 2013 Mar; 26(3):428-34. PubMed ID: 23080032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
